Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs

BACKGROUND: Radiogenetic therapy is a novel approach in the treatment of cancer, which employs genetic modification to alter the sensitivity of tumor cells to the effect of applied radiation. AIM: To select a potent radiation inducible promoter in the context of brain tumors and to investigate if CA...

Full description

Saved in:
Bibliographic Details
Published in:Clin Transl Med
Main Authors: Naoum, George E., Zhu, Zeng B., Buchsbaum, Donald J., Curiel, David T., Arafat, Waleed O.
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2017
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5332320/
https://ncbi.nlm.nih.gov/pubmed/28251571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-017-0140-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items